• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Therapeutics of hyperuricaemia and gout.

作者信息

Emmerson B T

出版信息

Med J Aust. 1984 Jul 7;141(1):31-6. doi: 10.5694/j.1326-5377.1984.tb132665.x.

DOI:10.5694/j.1326-5377.1984.tb132665.x
PMID:6738408
Abstract

Environmental factors, including diet, fluid intake and alcohol consumption, often contribute significantly to the development of hyperuricaemia. The contribution of these factors, together with body size and the renal excretory capacity for urate, can be assessed on the basis of the clinical history and examination, together with simple investigations. These include the measurement of both serum levels of urate and the urinary excretion of urate, and the effect of purine restriction on these measurements. Recognition of causative factors provides the potential for their correction. Should gout develop, serum urate levels must be reduced to normal. This usually, but not invariably, necessitates prolonged drug treatment. The major problem in maintaining serum urate levels within the normal range is that this depends upon the cooperation of the patient. Acute gout needs to be managed on its own merits, irrespective of the use of drugs which alter the serum urate concentration. Prophylactic therapy with colchicine reduces the frequency of acute attacks of gout, whether the serum urate level is normal or elevated.

摘要

相似文献

1
Therapeutics of hyperuricaemia and gout.
Med J Aust. 1984 Jul 7;141(1):31-6. doi: 10.5694/j.1326-5377.1984.tb132665.x.
2
Drug control of gout and hyperuricaemia.痛风和高尿酸血症的药物治疗
Drugs. 1978 Aug;16(2):158-66. doi: 10.2165/00003495-197816020-00005.
3
Milestones in the treatment of gout.痛风治疗的里程碑。
Am J Med. 1974 May;56(5):676-85. doi: 10.1016/0002-9343(74)90634-2.
4
Uricosuric therapy and urate solubility in blood and urine.促尿酸排泄疗法以及尿酸在血液和尿液中的溶解度
Postgrad Med J. 1979;55 Suppl 3:26-31.
5
Gout.痛风
JAMA. 1973 Apr 30;224(5 Suppl):757-66.
6
Drug treatment of gout.痛风的药物治疗
Semin Drug Treat. 1971 Sep;1(2):119-47.
7
Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.别嘌醇和苯溴马隆控制高尿酸血症的疗效。原发性慢性痛风治疗的病因学方法。
Ann Rheum Dis. 1998 Sep;57(9):545-9. doi: 10.1136/ard.57.9.545.
8
The treatment of gout.痛风的治疗。
Scott Med J. 1973;18:Suppl 1:249-50. doi: 10.1177/00369330730180s106.
9
The management of gout.痛风的管理
N Engl J Med. 1996 Feb 15;334(7):445-51. doi: 10.1056/NEJM199602153340707.
10
The management of gout.痛风的管理
Med J Aust. 1972 Mar 4;1(10):475-8. doi: 10.5694/j.1326-5377.1972.tb46879.x.

引用本文的文献

1
Allopurinol blocks shock-wave-induced rises in cytosolic calcium levels in MDCK cells.别嘌醇可阻断冲击波诱导的MDCK细胞胞质钙水平升高。
Urol Res. 1997;25(6):427-32. doi: 10.1007/BF01268861.
2
Crystal-associated rheumatic disease. Current management considerations.晶体相关性风湿性疾病。当前的管理考量因素。
Drugs. 1989 Apr;37(4):566-76. doi: 10.2165/00003495-198937040-00008.
3
Drug-induced rheumatic syndromes. Diagnosis, clinical features and management.药物性风湿综合征。诊断、临床特征与管理
Med Toxicol Adverse Drug Exp. 1989 May-Jun;4(3):199-218. doi: 10.1007/BF03259997.